NCT04449666 Hippocampal Volume and Memory Functions in Aneurysmal Subarachnoid Hemorrhage
| NCT ID | NCT04449666 |
| Status | Recruiting |
| Phase | — |
| Sponsor | BDH-Klinik Hessisch Oldendorf |
| Condition | Neurologic Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2020-06-15 |
| Primary Completion | 2026-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2020-06-15 with a primary completion date of 2026-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Neuropsychological and functional long-term consequences of subarachnoid hemorrhages (SAH) represent a great challenge, since sometimes considerable cognitive deficits occur without evidence of substantial brain damage. In this study, we want to examine if the frequently observed memory deficits are associated with hippocampal atrophy.
Eligibility Criteria
Inclusion Criteria: * neurological rehabilitation patients in phase B - D * at minimum eight weeks after disease onset * aneurysmal subarachnoid hemorrhage (Hunt \& Hess grade I or II) * written consent from the patient's legal representative * exclusion of pregnancy Exclusion Criteria: * insufficient cardiorespiratory stability * previous brain damage * mental disorders (dementia, depression) * colonization with multi-resistant pathogens * MRI contraindications * claustrophobia * weight \> 120 kg
Contact & Investigator
Jens D Rollnik, MD
STUDY DIRECTOR
BDH-Clinic Hessisch Oldendorf
Frequently Asked Questions
Who can join the NCT04449666 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Neurologic Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04449666 currently recruiting?
Yes, NCT04449666 is actively recruiting participants. Contact the research team at m.boltzmann@bdh-klinik-hessisch.oldendorf for enrollment information.
Where is the NCT04449666 trial being conducted?
This trial is being conducted at Hessisch Oldendorf, Germany.
Who is sponsoring the NCT04449666 clinical trial?
NCT04449666 is sponsored by BDH-Klinik Hessisch Oldendorf. The principal investigator is Jens D Rollnik, MD at BDH-Clinic Hessisch Oldendorf. The trial plans to enroll 30 participants.